Klin Farmakol Farm. 2011;25(2):92-94

Gastrointestinal bleeding due to warfarin drug interactions with ciprofloxacin

Jiří Holý, Pavel Havránek
Interní oddělení Nemocnice České Budějovice, a. s.

The authors document case history of an 81 years old male patient suffering from chronic bronchitis, diabetes mellitus of 2nd type and

chronic coronary artery disease who was taking warfarin because of chronic atrial fibrillation. The patient was using 3 different types

of antibiotics during the hospitalization, the last one was ciprofloxacin. On the 4th day of using of ciprofloxacin the patient started to

suffer from the extreme elevation of INR with bleeding to gastrointestinal tract. The bleeding was cured non-invasively; the treatment

of oral anticoagulation was stopped. After an exclusion of other possible causes the authors explain the developed status by a drug

interaction between warfarin and ciprofloxacin. During the hospitalization the patient took a lot of drugs with risk of drug interaction

with warfarin. The authors suppose that the prevention of thromboembolic complications by low molecular weight heparin is safer than

the prevention with warfarin in case of a polymorbid senior with fluctuant clinical status requiring a frequent change of the medication

when the avoidance of drugs with drug interaction with warfarin is impossible.

Keywords: warfarin, ciprofloxacin, drug interaction, inhibition, INR

Published: June 20, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Holý J, Havránek P. Gastrointestinal bleeding due to warfarin drug interactions with ciprofloxacin. Klin Farmakol Farm. 2011;25(2):92-94.
Download citation

References

  1. Perlík F. Klinická farmakologie v praxi. 1. vydání. Praha: Triton, 1999: 71-76.
  2. Katzung GB. Základní a klinická farmakologie. 8. vydání, 2. české. Jinočany: H & H Vyšehradská, s.r.o., 2006: 544-545.
  3. Souhrn údajů o přípravku Warfarin Orion 3 mg http://www.sukl.cz/download/spc/SPC3801.pdf.
  4. Kamada AK. Possible interaction between ciprofloxacin and warfarin. DICP 1990; 24(1): 27-28. Go to original source... Go to PubMed...
  5. Linville D 2nd, Emory C, Graves L 3rd. Ciprofloxacin and warfarin interaction. Am J Med 1991; 90(6): 765. Go to original source...
  6. Jolson HM, Tanner A, Green L, Grasela TH. Adverse reaction reporting of interaction between warfarin and fluoroquinolones. Arch Intern Med 1991; 151: 1003-1004. Go to original source...
  7. Dugoni - Kramer BM. Ciprofloxacin-warfarin interaction [letter]. Ann Pharmacother 1991; 25: 1397. Go to original source...
  8. Renzi R, Finbeiner S. Ciprofloxacin interaction with sodium warfarin: a potentially dangerous side effect. Am J Emerg Med., 1991; 9(6): 551-552. Go to original source... Go to PubMed...
  9. Ellis RJ, Mayo MS, Bodensteiner DM. Ciprofloxacin-warfarin coagulopathy: a case series. Am J Hematol 2000; 63(1): 28-31. Go to original source... Go to PubMed...
  10. Izrael DS, Stotka J, Rock W, et al. Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin. Clin Infect Dis 1996; 22: 251-256. Go to original source... Go to PubMed...
  11. Bianco TM, Bussey HI, Farnett LE, et al. Potential warfarin-ciprofloxacin interaction in patients receiving long - term anticoagulation. Pharmacotherapy 1992; 12(6): 435-439. Go to PubMed...
  12. Washington C, Hou SY, Hughes NC, et al. Ciprofloxacin prolonged - release tablets do not affect warfarin pharmacokinetics and pharmacodynamics. J Clin Pharmacol. 2007; 47(10): 1320-1326. Go to original source... Go to PubMed...
  13. Fischer HD, Juurling DN, Mamdani HM, et al. Hemorrhage durign warfarin therapy associated with cotrimoxazole and other urinary tract anti - infective agents: a population - based study. Arch Intern Med. 2010; 170: 617-621. Go to original source... Go to PubMed...
  14. Schelleman H, Bilker WB, Bresinger CM, et al. Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding. CLin Pharmacol Ther. 2008; 84: 581-588. Go to original source... Go to PubMed...
  15. Carolli DN, Carolli DG. Interactions between warfarin and free commonly prescribed fluorochinolones. Ann Pharmacother. 2008; 42: 680-685. Go to original source... Go to PubMed...
  16. Souhrn údajů o přípravku Ciphin pro infusione 200 mg/100 ml http://www.sukl.cz/download/spc/SPC103669.doc.
  17. Kompendium lékových interakcí pro PC. Infopharm, a.s., verze 2010.10.
  18. Schulman S, Beyth JR, Kearon C, et al. Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(Suppl 6): 257S-298S. Go to original source...
  19. Barkun A, Bardou M, Marshall JK. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003; 139: 843-857. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.